Skip to main content
VCbacked
Log inGet Started

ATB Therapeutics

Aye, Belgium

ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.

$57.2M raised
Nov 2024
Series A
BiotechnologyHealth CareTherapeutics

Top Investors

EQT Life SciencesMRL Ventures FundV-Bio VenturesSFPIMWE International

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about ATB Therapeutics

How much funding has ATB Therapeutics raised?
ATB Therapeutics has raised $57.2M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
Who are ATB Therapeutics's investors?
ATB Therapeutics's investors include EQT Life Sciences, MRL Ventures Fund, V-Bio Ventures, SFPIM, WE International.
Where is ATB Therapeutics headquartered?
ATB Therapeutics is headquartered in Aye, Belgium.
What does ATB Therapeutics do?
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
What stage is ATB Therapeutics at?
ATB Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"ATB Therapeutics — Funding & Investors." VCBacked, November 18, 2024, https://www.vcbacked.co/company/atb-therapeutics. Accessed July 4, 2026.
APA
VCBacked. (2024). ATB Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/atb-therapeutics
Wikipedia (cite web)
{{cite web |title=ATB Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/atb-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K